Skip to main content

Advertisement

ADVERTISEMENT

News

BioStem Technologies 

https://onlinelibrary.wiley.com/doi/10.1111/iwj.70096

BoStem Technologies announces breakthrough results of BioREtain-processed membranes RE-AC (AmnioWrap2) demonstrating a clear advantage in 12-week DFU healing rates compared to SoC. Results of the study have been published in the recent issue of the International Wound Journal.

Advertisement

Advertisement

Advertisement